PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
212.67%
Some net income increase while CRK is negative at -190.30%. John Neff would see a short-term edge over the struggling competitor.
-0.49%
Negative yoy D&A while CRK is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
382.89%
Lower deferred tax growth vs. CRK's 1350.00%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
154.37%
Slight usage while CRK is negative at -85.58%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
159.57%
Some yoy usage while CRK is negative at -144.71%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
6.84%
Some yoy increase while CRK is negative at -10.65%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
48.38%
Some CFO growth while CRK is negative at -32.86%. John Neff would note a short-term liquidity lead over the competitor.
-15.78%
Negative yoy CapEx while CRK is 9.05%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
5.77%
Acquisition growth of 5.77% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
224.47%
Purchases growth of 224.47% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
15.78%
Liquidation growth of 15.78% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-18.37%
Both yoy lines negative, with CRK at -100.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
0.47%
Lower net investing outflow yoy vs. CRK's 2.07%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both yoy lines negative, with CRK at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
100.00%
Buyback growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.